Kuti Baruch

Company: Immunobrain

Job title: Vice President Research & Development

Seminars:

Thinking Outside the Brain: Targeting the Peripheral Immune System to Treat Alzheimer’s Disease 1:30 pm

Utilizing immune checkpoint blockade for treating neurodegeneration: the advantage of targeting the peripheral immune system Drug development and translational work of IBC-Ab002, a novel anti-PD-L1 antibody tailored for treating Alzheimer's disease Early insights from IBC-01-01, a Phase I clinical study in persons with early Alzheimer's diseaseRead more

day: Translational Track Day 2 PM